DDR is a novel, low-dose X-ray imaging technique available on Konica Minolta Healthcare ... can address specific needs and lead to better decisions, sooner. DOWNLOAD THE DIGITAL EDITION APP ...

The industry is anticipated to exhibit a Y-o-Y growth of 6.1% in 2024. The digital mobile X-ray devices market is an important segment of the medical imaging industry that focuses on providing ...

Credit: Emory Healthcare, Dr. Eric R. Wagner. DDR is a novel, low-dose X-ray imaging technique available on Konica Minolta Healthcare DR Systems that captures both static images and cinegrams ...

Dr. M. Blair Marshall, thoracic oncology surgeon with the Jellison Cancer Institute, was the first physician on the Gulf Coast to use the technology ...

Investopedia / Jiaqi Zhou The digital divide is the gap created by unequal access to modern telecommunications technology among different demographic groups and regions. This can include ...

will host a conference call to review these results and provide a busin By Karen Roman Medical tech company Nano-X Imaging Ltd. (Nasdaq: NNOX) said Nanox.ARC, its digital multi-source 3D ...

Onc.AI is a digital health company developing AI-driven oncology clinical management solutions using advanced Deep Learning applied to routine diagnostic images. The company's platform is applied at ...

New robotic technology has arrived at Puyallup’s MultiCare Good Samaritan Hospital – and it creates a world of difference for ...

The realm of medical imaging is undergoing a transformative shift with the rapid integration of Artificial Intelligence (AI). This evolution necessitates ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. TechRadar started testing cameras almost 20 years ago. Since then, our expert team has ...

Annual Meeting held in Chicago, IL, was host to a State of the Science session on novel diagnostics and therapeutics in renal cell and urothelial carcinomas. Dr. Michael Hofman presented an in-depth ...

Machine-learning (ML) model predictive for chemotherapy toxicity and termination in a real-world community oncology practice. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...